Biomerica (BMRA) Total Current Liabilities (2011 - 2026)
Biomerica (BMRA) reported Total Current Liabilities of $1.6 million for Q1 2026, down 5.34% on a YoY basis from $1.6 million in Q1 2025, and down 2.38% sequentially from $1.6 million in Q4 2025.
Biomerica (BMRA) Total Current Liabilities (2011 - 2026) Analysis & Trends
Biomerica (BMRA) has 16 years of Total Current Liabilities data on file, last reported at $1.6 million in Q1 2026.
- For the quarter ending Q1 2026, Total Current Liabilities fell 5.34% year-over-year to $1.6 million; the trailing twelve-month figure through Feb 2026 stood at $1.6 million (down 5.34% YoY), and the FY2025 full-year result was $1.7 million, down 21.05% from the prior year.
- Total Current Liabilities fell to $1.6 million in Q1 2026, from $1.6 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $6.7 million in Q1 2022 to a low of $1.4 million in Q1 2023.
- A 5-year average of $2.1 million and a median of $1.8 million in 2022 frame the typical range for Total Current Liabilities.
- Across the five-year window, Total Current Liabilities jumped 395.41% in 2022 and plunged 79.17% in 2023, its largest moves.
- Tracing BMRA's Total Current Liabilities over 5 years: stood at $1.8 million in 2022, then rose by 3.33% to $1.8 million in 2023, then climbed by 2.96% to $1.9 million in 2024, then declined by 14.77% to $1.6 million in 2025, then decreased by 2.38% to $1.6 million in 2026.
- Business Quant data shows BMRA's Total Current Liabilities at $1.6 million in Q1 2026, $1.6 million in Q4 2025, and $1.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 18.38 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 6.32 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 11.66 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 4.57 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 1.41 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 2.22 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 8.70 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 8.53 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 1.60 Bn |
| 10 | Biomerica | 4.85 Mn | 3.51 Mn | -44,000.00 | 1.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 1.56 Mn |
| Nov 30, 2025 | 1.60 Mn |
| Aug 31, 2025 | 1.69 Mn |
| May 31, 2025 | 1.74 Mn |
| Feb 28, 2025 | 1.65 Mn |
| Nov 30, 2024 | 1.88 Mn |
| Aug 31, 2024 | 2.15 Mn |
| May 31, 2024 | 2.20 Mn |
| Feb 29, 2024 | 1.99 Mn |
| Nov 30, 2023 | 1.82 Mn |
| Aug 31, 2023 | 1.75 Mn |
| May 31, 2023 | 1.95 Mn |
| Feb 28, 2023 | 1.40 Mn |
| Nov 30, 2022 | 1.76 Mn |
| Aug 31, 2022 | 1.76 Mn |
| May 31, 2022 | 2.01 Mn |
| Feb 28, 2022 | 6.70 Mn |
| Nov 30, 2021 | 4.74 Mn |
| Aug 31, 2021 | 1.48 Mn |
| May 31, 2021 | 1.30 Mn |